IGF-1 LR3 vs MGF (Mechano Growth Factor)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

✅ Stacking Partners — These compounds are commonly used together and may have synergistic effects.
⚠️ Known Interaction
LOW Complementary timing — MGF post-workout for satellite cell activation, IGF-1 LR3 later for growth signaling.
IGF-1 LR3MGF (Mechano Growth Factor)
CategoryGrowth FactorsGrowth Factors
Standard DoseResearch indicates 20-50 mcg daily via subcutaneous or intramuscular injection.Research indicates 100-200 mcg per injection site, administered bilaterally into target muscles immediately post-workout.
TimingPost-workout administration for muscle growth. Can be injected locally (intramuscularly) into target muscle groups. Morning dosing on rest days.Immediately post-workout (within 5-10 minutes) for optimal satellite cell activation. Must be injected directly into the trained muscle.
Cycle Duration4-6 week cycles maximum. Longer cycles risk significant side effects and receptor desensitization.4-6 week cycles.
Evidence Levelmoderate_humananimal_plus_anecdotal
A

IGF-1 LR3

Growth Factors

Mechanism

IGF-1 LR3 (Long Arginine 3-IGF-1) is an 83-amino acid synthetic analog of IGF-1 with an arginine substitution at position 3 and 13 additional N-terminal amino acids. These modifications eliminate binding to IGF-binding proteins, making it approximately 3x more potent than native IGF-1 with a half-life of 20-30 hours (vs 12-15 minutes for native IGF-1). It activates the IGF-1R tyrosine kinase receptor, triggering IRS-1/PI3K/Akt/mTOR and PI3K/Akt/GSK3-beta pathways to drive protein synthesis, muscle hypertrophy, and hyperplasia (new muscle cell formation).

Standard Dosing

Research indicates 20-50 mcg daily via subcutaneous or intramuscular injection.

Timing

Post-workout administration for muscle growth. Can be injected locally (intramuscularly) into target muscle groups. Morning dosing on rest days.

Cycle Duration

4-6 week cycles maximum. Longer cycles risk significant side effects and receptor desensitization.

Side Effects

  • Hypoglycemia (primary danger — can be severe)
  • Organ and intestinal growth with chronic use
  • Joint pain
  • Jaw/hand growth (prolonged use)
  • Increased tumor risk
  • Water retention
  • Neuropathy

Contraindications

  • Active cancer or history of cancer (IGF-1 is a potent growth factor for tumors)
  • Diabetic retinopathy
  • Pregnancy and breastfeeding
  • Acromegaly features
  • Under 25 years of age (growth plate concerns)

Best Stacking Partners

HGHMGFPEG-MGF

Mechanism

MGF is the E domain peptide of the IGF-1Ec splice variant, produced when the IGF-1 gene is mechanically spliced in response to muscle damage or exercise. It activates satellite cells (muscle stem cells), promoting their proliferation and preventing premature differentiation. After exercise/injury, IGF-1 gene is first spliced toward MGF (proliferation phase) then shifts to IGF-1Ea (differentiation phase). MGF uniquely drives the initial proliferative response, expanding the pool of myogenic precursor cells before they fuse with existing muscle fibers.

Standard Dosing

Research indicates 100-200 mcg per injection site, administered bilaterally into target muscles immediately post-workout.

Timing

Immediately post-workout (within 5-10 minutes) for optimal satellite cell activation. Must be injected directly into the trained muscle.

Cycle Duration

4-6 week cycles.

Side Effects

  • Injection site pain/swelling
  • Hypoglycemia (less than IGF-1 LR3)
  • Localized inflammation

Contraindications

  • Active cancer
  • Pregnancy and breastfeeding
  • Under 25 years of age

Best Stacking Partners

PEG-MGFIGF-1 LR3HGH

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →